CBIO News and Press, Catalyst Biosciences Inc. From 07/06/22

Court Denies JDS1’s Motion for Expedited Proceedings Board Reiterates Commitment to Distributing Cash to Stockholders Once Potential Liability and Expenses Associated with Stockholder Litigation and Proxy Contest Are Known SOUTH SAN FRANCISCO, Calif., July 06, 2022 ...

Gainers: Allena Pharmaceuticals ( ALNA ) +191% . Brickell Biotech ( BBI ) +78% . Decibel Therapeutics ( DBTX ) +35% . Cognition Therapeutics ( CGTX ) +26% . Akouos ( AKUS ) +20% . Fujian Blue Hat Interactive Entertainment Tec...

Gainers: Allena Pharmaceuticals ( ALNA ) +238% . Trevi Therapeutics TRVI +29% . Bellerophon Therapeutics ( BLPH ) +22% . Agenus ( AGEN ) +21% . Catalyst Biosciences CBIO +18% . Losers: Agile Therapeutics ( AGRX ) -29% . ...

Catalyst Biosciences ( NASDAQ: CBIO ) has announced its intention to distribute cash to the Co.’s stockholders through one or more distributions. The intention of the Co.’s Board is to maximize the size of the total distribution after satisfying or reser...

Board is Committed to Maximizing the Amount of Cash the Company Distributes to Stockholders Decision Follows Recent Sale of Certain Assets and Extensive Engagement with Stockholders Board Will Set Initial Distribution Date and Amount Once Potential Liability and Expenses...

Penny stocks are red hot right now if you know where to look. The overall market has gotten beaten up due to concerns over high inflation and expectations of a recession in 2022. But some have found resolve in day trading or swing trading stocks instead of taking a long-term approach to...

3 Hot Penny Stocks to Add to Your Watchlist This Week While markets ended on Wednesday, May 25th with some gains, there is still a lot left to be desired with penny stocks and blue chips. Right now, we are seeing major volatility across the board. And this volatility is characterized by...

Verrica Pharmaceuticals VRCA -54% downgraded at RBC as FDA snubs skin disease therapy. Super Group SGHC -14% on Q1 results. DICK'S Sporting Goods DKS -13% on dire forecast for full-year sales. Better Therapeutics (BTTX) -13%. Academy Sports and Outdoors (ASO) -9%...

Everyone seems to have a strategy when it comes to cheap stocks to buy. Maybe it’s finding the direction of the wind or seeing if a solar eclipse is coming. All joking aside, there are some pretty unique “strategies” that traders use to build their watch list. On a more...

Snap (SNAP) -30% as it warns on EBITDA, revenues, deteriorating economy; social media peers tumble. BigBear.ai Holdings (BBAI) -26%. Abercrombie & Fitch (ANF) -25% on Q1 earnings release. GeoVax Labs (GOVX) -22% after Moderna enters monkeypox vaccine developm...